- 商品介绍
- 规格参数
- 包装参数
规格 |
|
Accession Number: | NM_000680 |
Assay Entry: | Cell-based beta lactamase reporter gene |
Cell Line: | CHO-K1 |
Cell State: | Division-Arrested Cells |
Druggable Target: | GPCRs |
Gene Symbol: | ADRA1A |
Population Status: | Pool of Stable Cells |
Product Line: | GeneBLAzer® |
Reporter Gene: | BLA (Beta-Lactamase) |
System Type: | GeneBLAzer™ |
Target Entry: | ADRA1A |
Detection Method: | Fluorescent |
储存 |
|
Each kit contains sufficient quantities of division arrested (DA) cells and substrate to assay 1 x 384 well plate. (Other materials are required separately; please refer to the protocol). Includes: o GeneBLAzer® ADRA1A CHO-K1DA cells o LiveBLAzer™-FRET B/G Loading Kit, 70µg o Solution D o GeneBLAzer® ADRA1A CHO-K1Assay Protocol o LiveBLAzer™-FRET B/G Loading Protocol o Certificate of Analysis The GeneBLAzer® ADRA1A CHO-K1 DA cells are shipped on dry ice and should be stored in liquid nitrogen immediately upon receipt. |
描述 |
The GeneBLAzer® ADRA1A CHO-K1 DA (Division Arrested) cells contain the human Adrenergic Alpha-1A Receptor (ADRA1A), (Accession # NM_000680) stably integrated into the CellSensor™ NFAT-bla CHO-K1 cell line. CellSensor™ NFAT-bla CHO-K1 cells (Cat # K1078) contain a beta-lactamase (bla) reporter gene under control of the NFAT response element.
Both ADRA1A CHO-K1 DA cells are functionally validated for Z'-factor and EC50 concentrations of Phenylephrine. In addition, ADRA1A-NFAT-bla CHO-K1 cells have been tested for assay performance under variable conditions. These data are found in the Validation & Assay Performance Summary in the Manuals and Brochures section. DA cells are irreversibly division arrested using a low-dose treatment of Mitomycin C, and have no apparent toxicity or change in cellular signal transduction.
长度(mm) | |
宽度(mm) | |
高度(mm) | |
重量(kg) |